Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. CHGCY Peers
See (CHGCY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHGCY | $26.07 | +0.93% | 85.8B | 29.97 | $0.87 | +0.93% |
| RHHVF | $317.00 | +1.37% | 256.1B | 25.32 | $12.52 | +3.47% |
| RHHBY | $39.51 | +0.61% | 255.3B | 25.17 | $1.57 | +3.45% |
| RHHBF | $328.00 | -3.24% | 247.6B | 26.16 | $12.54 | +3.28% |
| AZNCF | $143.10 | -0.61% | 221.9B | 28.79 | $4.97 | +2.21% |
| NVSEF | $110.25 | -1.82% | 209.2B | 17.28 | $6.38 | +3.59% |
| SNYNF | $104.20 | +0.14% | 126.9B | 18.25 | $5.71 | +4.20% |
| BMYMP | $790.00 | N/A | 95.6B | 3511.11 | $0.23 | +0.13% |
| CHGCF | $52.00 | -6.34% | 85.6B | 29.71 | $1.75 | +0.01% |
| GLAXF | $19.00 | -2.36% | 77B | 18.45 | $1.03 | +4.26% |
Stock Comparison
CHGCY vs RHHVF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, RHHVF has a market cap of 256.1B. Regarding current trading prices, CHGCY is priced at $26.07, while RHHVF trades at $317.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas RHHVF's P/E ratio is 25.32. In terms of profitability, CHGCY's ROE is +0.17%, compared to RHHVF's ROE of +0.35%. Regarding short-term risk, CHGCY is more volatile compared to RHHVF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs RHHBY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, RHHBY has a market cap of 255.3B. Regarding current trading prices, CHGCY is priced at $26.07, while RHHBY trades at $39.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas RHHBY's P/E ratio is 25.17. In terms of profitability, CHGCY's ROE is +0.17%, compared to RHHBY's ROE of +0.35%. Regarding short-term risk, CHGCY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs RHHBF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, RHHBF has a market cap of 247.6B. Regarding current trading prices, CHGCY is priced at $26.07, while RHHBF trades at $328.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas RHHBF's P/E ratio is 26.16. In terms of profitability, CHGCY's ROE is +0.17%, compared to RHHBF's ROE of +0.35%. Regarding short-term risk, CHGCY is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs AZNCF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, AZNCF has a market cap of 221.9B. Regarding current trading prices, CHGCY is priced at $26.07, while AZNCF trades at $143.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas AZNCF's P/E ratio is 28.79. In terms of profitability, CHGCY's ROE is +0.17%, compared to AZNCF's ROE of +0.19%. Regarding short-term risk, CHGCY is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs NVSEF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, NVSEF has a market cap of 209.2B. Regarding current trading prices, CHGCY is priced at $26.07, while NVSEF trades at $110.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas NVSEF's P/E ratio is 17.28. In terms of profitability, CHGCY's ROE is +0.17%, compared to NVSEF's ROE of +0.31%. Regarding short-term risk, CHGCY is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs SNYNF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, SNYNF has a market cap of 126.9B. Regarding current trading prices, CHGCY is priced at $26.07, while SNYNF trades at $104.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas SNYNF's P/E ratio is 18.25. In terms of profitability, CHGCY's ROE is +0.17%, compared to SNYNF's ROE of +0.10%. Regarding short-term risk, CHGCY is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs BMYMP Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, BMYMP has a market cap of 95.6B. Regarding current trading prices, CHGCY is priced at $26.07, while BMYMP trades at $790.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas BMYMP's P/E ratio is 3511.11. In terms of profitability, CHGCY's ROE is +0.17%, compared to BMYMP's ROE of +0.32%. Regarding short-term risk, CHGCY is more volatile compared to BMYMP. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs CHGCF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, CHGCF has a market cap of 85.6B. Regarding current trading prices, CHGCY is priced at $26.07, while CHGCF trades at $52.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas CHGCF's P/E ratio is 29.71. In terms of profitability, CHGCY's ROE is +0.17%, compared to CHGCF's ROE of +0.17%. Regarding short-term risk, CHGCY is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs GLAXF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, GLAXF has a market cap of 77B. Regarding current trading prices, CHGCY is priced at $26.07, while GLAXF trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas GLAXF's P/E ratio is 18.45. In terms of profitability, CHGCY's ROE is +0.17%, compared to GLAXF's ROE of +0.22%. Regarding short-term risk, CHGCY is less volatile compared to GLAXF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs DSNKY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, DSNKY has a market cap of 50.5B. Regarding current trading prices, CHGCY is priced at $26.07, while DSNKY trades at $27.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas DSNKY's P/E ratio is 24.81. In terms of profitability, CHGCY's ROE is +0.17%, compared to DSNKY's ROE of +0.15%. Regarding short-term risk, CHGCY is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs DSKYF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, DSKYF has a market cap of 46.9B. Regarding current trading prices, CHGCY is priced at $26.07, while DSKYF trades at $25.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas DSKYF's P/E ratio is 23.03. In terms of profitability, CHGCY's ROE is +0.17%, compared to DSKYF's ROE of +0.11%. Regarding short-term risk, CHGCY is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs BAYRY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, BAYRY has a market cap of 27.7B. Regarding current trading prices, CHGCY is priced at $26.07, while BAYRY trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas BAYRY's P/E ratio is -7.43. In terms of profitability, CHGCY's ROE is +0.17%, compared to BAYRY's ROE of -0.08%. Regarding short-term risk, CHGCY is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs OTSKY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, OTSKY has a market cap of 25B. Regarding current trading prices, CHGCY is priced at $26.07, while OTSKY trades at $23.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas OTSKY's P/E ratio is 10.43. In terms of profitability, CHGCY's ROE is +0.17%, compared to OTSKY's ROE of +0.03%. Regarding short-term risk, CHGCY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs OTSKF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, OTSKF has a market cap of 24.9B. Regarding current trading prices, CHGCY is priced at $26.07, while OTSKF trades at $47.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas OTSKF's P/E ratio is 10.51. In terms of profitability, CHGCY's ROE is +0.17%, compared to OTSKF's ROE of +0.03%. Regarding short-term risk, CHGCY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs ORINY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, ORINY has a market cap of 19B. Regarding current trading prices, CHGCY is priced at $26.07, while ORINY trades at $33.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas ORINY's P/E ratio is 23.77. In terms of profitability, CHGCY's ROE is +0.17%, compared to ORINY's ROE of +0.37%. Regarding short-term risk, CHGCY is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs ALPMY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, ALPMY has a market cap of 17.4B. Regarding current trading prices, CHGCY is priced at $26.07, while ALPMY trades at $9.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas ALPMY's P/E ratio is 48.51. In terms of profitability, CHGCY's ROE is +0.17%, compared to ALPMY's ROE of +0.01%. Regarding short-term risk, CHGCY is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs ALPMF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, ALPMF has a market cap of 17.1B. Regarding current trading prices, CHGCY is priced at $26.07, while ALPMF trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas ALPMF's P/E ratio is 47.75. In terms of profitability, CHGCY's ROE is +0.17%, compared to ALPMF's ROE of +0.01%. Regarding short-term risk, CHGCY is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs GIKLY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, GIKLY has a market cap of 14.2B. Regarding current trading prices, CHGCY is priced at $26.07, while GIKLY trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas GIKLY's P/E ratio is 41.00. In terms of profitability, CHGCY's ROE is +0.17%, compared to GIKLY's ROE of +0.03%. Regarding short-term risk, CHGCY is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs CSPCY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, CSPCY has a market cap of 11B. Regarding current trading prices, CHGCY is priced at $26.07, while CSPCY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas CSPCY's P/E ratio is 19.10. In terms of profitability, CHGCY's ROE is +0.17%, compared to CSPCY's ROE of +0.18%. Regarding short-term risk, CHGCY is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs RCDTF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, RCDTF has a market cap of 10.1B. Regarding current trading prices, CHGCY is priced at $26.07, while RCDTF trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas RCDTF's P/E ratio is 21.49. In terms of profitability, CHGCY's ROE is +0.17%, compared to RCDTF's ROE of +0.22%. Regarding short-term risk, CHGCY is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs KYKOF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, KYKOF has a market cap of 8.3B. Regarding current trading prices, CHGCY is priced at $26.07, while KYKOF trades at $15.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas KYKOF's P/E ratio is 23.24. In terms of profitability, CHGCY's ROE is +0.17%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CHGCY is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs HAWPY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, HAWPY has a market cap of 8B. Regarding current trading prices, CHGCY is priced at $26.07, while HAWPY trades at $35.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas HAWPY's P/E ratio is 17.89. In terms of profitability, CHGCY's ROE is +0.17%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CHGCY is less volatile compared to HAWPY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs CHJTF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, CHJTF has a market cap of 7.1B. Regarding current trading prices, CHGCY is priced at $26.07, while CHJTF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas CHJTF's P/E ratio is 12.40. In terms of profitability, CHGCY's ROE is +0.17%, compared to CHJTF's ROE of +0.18%. Regarding short-term risk, CHGCY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs GIFOF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, GIFOF has a market cap of 6.7B. Regarding current trading prices, CHGCY is priced at $26.07, while GIFOF trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas GIFOF's P/E ratio is 31.73. In terms of profitability, CHGCY's ROE is +0.17%, compared to GIFOF's ROE of +0.03%. Regarding short-term risk, CHGCY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs ORINF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, ORINF has a market cap of 6B. Regarding current trading prices, CHGCY is priced at $26.07, while ORINF trades at $43.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas ORINF's P/E ratio is 17.42. In terms of profitability, CHGCY's ROE is +0.17%, compared to ORINF's ROE of +0.37%. Regarding short-term risk, CHGCY is less volatile compared to ORINF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs GIFLF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, GIFLF has a market cap of 5.9B. Regarding current trading prices, CHGCY is priced at $26.07, while GIFLF trades at $9.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas GIFLF's P/E ratio is 36.65. In terms of profitability, CHGCY's ROE is +0.17%, compared to GIFLF's ROE of +0.03%. Regarding short-term risk, CHGCY is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs DPHAY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CHGCY is priced at $26.07, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CHGCY's ROE is +0.17%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CHGCY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs OPHLY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, OPHLY has a market cap of 5B. Regarding current trading prices, CHGCY is priced at $26.07, while OPHLY trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas OPHLY's P/E ratio is 14.08. In terms of profitability, CHGCY's ROE is +0.17%, compared to OPHLY's ROE of +0.10%. Regarding short-term risk, CHGCY is less volatile compared to OPHLY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs OPHLF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, OPHLF has a market cap of 4.8B. Regarding current trading prices, CHGCY is priced at $26.07, while OPHLF trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas OPHLF's P/E ratio is 13.56. In terms of profitability, CHGCY's ROE is +0.17%, compared to OPHLF's ROE of +0.10%. Regarding short-term risk, CHGCY is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs SNPHF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, SNPHF has a market cap of 4.3B. Regarding current trading prices, CHGCY is priced at $26.07, while SNPHF trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas SNPHF's P/E ratio is 17.32. In terms of profitability, CHGCY's ROE is +0.17%, compared to SNPHF's ROE of +0.06%. Regarding short-term risk, CHGCY is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs SNPHY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, SNPHY has a market cap of 4B. Regarding current trading prices, CHGCY is priced at $26.07, while SNPHY trades at $11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas SNPHY's P/E ratio is 15.56. In terms of profitability, CHGCY's ROE is +0.17%, compared to SNPHY's ROE of +0.06%. Regarding short-term risk, CHGCY is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs PTKFF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, PTKFF has a market cap of 3.4B. Regarding current trading prices, CHGCY is priced at $26.07, while PTKFF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CHGCY's ROE is +0.17%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, CHGCY is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs VRBCF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, VRBCF has a market cap of 2.7B. Regarding current trading prices, CHGCY is priced at $26.07, while VRBCF trades at $324.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas VRBCF's P/E ratio is 16.40. In terms of profitability, CHGCY's ROE is +0.17%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, CHGCY is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs HAWPF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, HAWPF has a market cap of 2.2B. Regarding current trading prices, CHGCY is priced at $26.07, while HAWPF trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas HAWPF's P/E ratio is 12.50. In terms of profitability, CHGCY's ROE is +0.17%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CHGCY is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs LYPHF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, LYPHF has a market cap of 960M. Regarding current trading prices, CHGCY is priced at $26.07, while LYPHF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas LYPHF's P/E ratio is 12.76. In terms of profitability, CHGCY's ROE is +0.17%, compared to LYPHF's ROE of +0.06%. Regarding short-term risk, CHGCY is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs CMOPF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, CMOPF has a market cap of 880.8M. Regarding current trading prices, CHGCY is priced at $26.07, while CMOPF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas CMOPF's P/E ratio is 5.96. In terms of profitability, CHGCY's ROE is +0.17%, compared to CMOPF's ROE of +0.14%. Regarding short-term risk, CHGCY is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs TGRNF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, TGRNF has a market cap of 851.7M. Regarding current trading prices, CHGCY is priced at $26.07, while TGRNF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas TGRNF's P/E ratio is 11.08. In terms of profitability, CHGCY's ROE is +0.17%, compared to TGRNF's ROE of +0.09%. Regarding short-term risk, CHGCY is less volatile compared to TGRNF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs JCRRF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, JCRRF has a market cap of 636M. Regarding current trading prices, CHGCY is priced at $26.07, while JCRRF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas JCRRF's P/E ratio is -261.00. In terms of profitability, CHGCY's ROE is +0.17%, compared to JCRRF's ROE of -0.01%. Regarding short-term risk, CHGCY is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs MAYNF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, MAYNF has a market cap of 307.9M. Regarding current trading prices, CHGCY is priced at $26.07, while MAYNF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas MAYNF's P/E ratio is -3.75. In terms of profitability, CHGCY's ROE is +0.17%, compared to MAYNF's ROE of -0.35%. Regarding short-term risk, CHGCY is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs PTKFY Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, PTKFY has a market cap of 20.5M. Regarding current trading prices, CHGCY is priced at $26.07, while PTKFY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas PTKFY's P/E ratio is 20.00. In terms of profitability, CHGCY's ROE is +0.17%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, CHGCY is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs PSYGF Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, PSYGF has a market cap of 1.1M. Regarding current trading prices, CHGCY is priced at $26.07, while PSYGF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas PSYGF's P/E ratio is -0.02. In terms of profitability, CHGCY's ROE is +0.17%, compared to PSYGF's ROE of +2.78%. Regarding short-term risk, CHGCY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.
CHGCY vs CRXTQ Comparison
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 85.8B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, CHGCY is priced at $26.07, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.97, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, CHGCY's ROE is +0.17%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, CHGCY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.